(Photo Credit - Intec Pharma)
We're happy to announce that as of the close of trading today, we now have a marijuana stock profile for Intec Pharma, Ltd. (NASDAQ:NTEC) (TASE:NTEC).
Intec's product pipeline includes four product candidates in clinical trial stages including an "Accordion Pill" shown above with the commonly known cannabinoids cannabidiol and tetrahydrocannabinol. This treatment is being developed for various conditions including low back neuropathic pain and fibromyalgia.
This is the second Israeli-listed company to be included in our database. Beyond that, since shares are listed on the Nasdaq, Intec Pharma is one of the few marijuana stocks that can be traded commission-free using the Robinhood app.
Intec Pharma Ltd. has been added to the following marijuana stock databases:
To learn more about Intec Pharma and what they're up to in the world of cannabinoid-based treatments, be sure to check out their stock profile here. Be sure to subscribe to our free newsletter so that you never miss an important marijuana stock update!
Now check out Therapix Biosciences Ltd., another Israeli cannabis company.